Immunological Aspects of Gastrointestinal Diseases

A special issue of Gastroenterology Insights (ISSN 2036-7422). This special issue belongs to the section "Gastrointestinal Disease".

Deadline for manuscript submissions: 31 October 2025 | Viewed by 2106

Special Issue Editor


E-Mail Website
Guest Editor
Medical Faculty, Sofia University St. Kliment Ohridski, Sofia, Bulgaria
Interests: immunology; clinical Immunology; autoimmunity; autoimmune diseases; inflammation; cytokines; immune regulation; vaccines
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue of "Immunological Aspects of Gastrointestinal Diseases" intends to be not just a collection of research findings but a platform that actively fosters academic exchange and collaboration within the field of gastrointestinal immunology topics, from fundamental immunology research to clinical applications. By focusing on the immunological dimension of gastrointestinal diseases as well as the intricate interplay between immune mechanisms and the onset, progression, and treatment of gastrointestinal diseases, it consolidates the latest research findings from across the globe.

The gastrointestinal tract's mucosal immune system plays a pivotal role in defending against foreign pathogens, actively interacting with the gut microbiota, and maintaining immune tolerance in the gut. Therefore, this Special Issue will prioritize advancements in the immunological pathogenesis of gastrointestinal diseases, immune modulation strategies, and immunology-based therapeutic approaches. Additionally, it will explore the roles of key elements such as THE gut microbiota, immune cell subsets, and immune molecular networks in gastrointestinal diseases, offering novel insights and directions for disease prevention, diagnosis, and treatment.

Dr. Tsvetelina Velikova
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gastroenterology Insights is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gastrointestinal diseases
  • immunology
  • mucosal immune system
  • intestinal inflammation
  • immune tolerance
  • inflammatory bowel disease (IBD)
  • crohn’s disease
  • ulcerative colitis
  • gut microbiota
  • immunomodulation
  • immunotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

11 pages, 290 KiB  
Review
The Association Between Crohn’s Disease and Patient Response to Yeast: A Review of the Literature
by Xavier Zonna, Conor Banta and Nariman Hossein-Javaheri
Gastroenterol. Insights 2024, 15(4), 1064-1074; https://doi.org/10.3390/gastroent15040073 - 10 Dec 2024
Viewed by 1524
Abstract
Inflammatory bowel disease represents a wide range of pathologies and disease states including Crohn’s Disease (CD) and Ulcerative colitis (UC). Despite extensive research, the exact immunopathogenesis of Crohn’s disease remains unclear, but a variety of studies over the years have pointed to yeast [...] Read more.
Inflammatory bowel disease represents a wide range of pathologies and disease states including Crohn’s Disease (CD) and Ulcerative colitis (UC). Despite extensive research, the exact immunopathogenesis of Crohn’s disease remains unclear, but a variety of studies over the years have pointed to yeast as a potential source antigen of uncertain significance. The aim of this review is to summarize the current literature investigating the association between Crohn’s disease patients and their responses to yeast. To do this, we performed a literature review by looking at clinical and translational research regarding the immunopathogenesis of Crohn’s disease, yeast and its associated biomarkers, and overall patient response to dietary yeast published between 1 January 1990 and 1 October 2024 that were indexed on PubMed and Google Scholar with the majority written in English. It was found that antibodies against Saccharomyces cerevisiae (ASCA) have proven to be highly specific for CD during the workup of IBD and may have diagnostic value for the purpose of excluding ulcerative colitis. For CD patients, there appears to be a dysregulated immune response to antigens like yeast that results in abnormal mucosal permeability and thus increases antigen presentation to the immune system. In addition, ASCA and its immunoglobulin modifications have been shown to have significant potential in the prediction of CD onset and disease course. Interestingly, although other abnormally structured antibodies can be found in CD patients’ serum for years preceding diagnosis, there appears to be no relation between ASCA and dietary yeast sensitivity by CD patients. In conclusion, significant research efforts have been made in recent years to explore the role of diet in the disease course and management of patients with Crohn’s disease. The immunological role of antigens including yeast in CD is complex and may represent an important pathogenetic factor in addition to influencing the specific phenotype of the disease. Unfortunately, no single specific diet is superior for the management of IBD, and individualized patient treatment by experts in the field is best for adjunctive therapy. New studies characterizing the microbiome of CD patients and also using immune markers/gene modifications to predict disease outcomes have shown to be quite promising. However, further research is required to investigate the CD yeast response and its role in the pathogenesis, diagnosis and treatment of CD. Full article
(This article belongs to the Special Issue Immunological Aspects of Gastrointestinal Diseases)
Back to TopTop